Efficacy and Safety of Sacubitril/Valsartan in Hemodialysis Patients with Chronic Heart Failure: A Retrospective Study at a Single Center
Medical Science Monitor · 2024
DOI: 10.12659/msm.943529 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Science Monitor, 2024. Verfasst von Zhuan'e Yao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Shaanxi Second Provincial People's Hospital, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Heart Failure, Valsartan, Drug Combinations, Aminobutyrates. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Shaanxi Second Provincial People's Hospital, Xi'an, Shaanxi, China.
- Department of Nephrology, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, China.
Zitieren
APA
Yao, Z., Wang, P., Fu, Q., Song, Q., Liu, A., Li, H., Wang, W., & Zhang, P. (2024). Efficacy and Safety of Sacubitril/Valsartan in Hemodialysis Patients with Chronic Heart Failure: A Retrospective Study at a Single Center. Medical Science Monitor. https://doi.org/10.12659/msm.943529
Vancouver
Yao Z, Wang P, Fu Q, Song Q, Liu A, Li H, et al. Efficacy and Safety of Sacubitril/Valsartan in Hemodialysis Patients with Chronic Heart Failure: A Retrospective Study at a Single Center. Medical Science Monitor. 2024. doi:10.12659/msm.943529
BibTeX
@article{Yao2024,
author = {Yao, Zhuan'e and Wang, Pengbo and Fu, Qinjuan and Song, Qiong and Liu, Ai and Li, Huan and Wang, Wei and Zhang, Peng},
title = {Efficacy and Safety of Sacubitril/Valsartan in Hemodialysis Patients with Chronic Heart Failure: A Retrospective Study at a Single Center},
journal = {Medical Science Monitor},
year = {2024},
doi = {10.12659/msm.943529}
}
EUVIMED